Viewing Study NCT05949593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-28 @ 8:47 PM
Study NCT ID: NCT05949593
Status: RECRUITING
Last Update Posted: 2025-02-14
First Post: 2023-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Sponsor: Belite Bio, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Geographic Atrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LBS-008 View
None Tinlarebant View
None GA View